Accessibility statement

Virtual ISPOR Europe 2021

Contributions from CHE researchers

30 November – 3 December 2021



On demand presentation, available to watch from the 22nd November. Issues with Health Technology Assessment of Specialised Technologies (16.30 -16.45). Rita Faria presents ' Better outcomes and value for money with cost-effectiveness modelling of cascade screening strategies for familial hypercholesterolaemia. 

Tuesday 30 November

Defining established clinical management in the era of managed access in HTA

Mark Sculpher will be a panelist on this session.

Issue panels and workshops 12.30 -13.30


What are the benefits of treatment of familial hypercholesterolaemia? A cost-effectiveness model based on real-world data considering cholesterol burden

Poster presentation by Rita Faria 

Virtual poster discussion session 1 13.30 - 16.00


Wednesday 1 December

Methods to estimate the value of new antibiotics in the context of antimicrobial resistance

Session moderator Mark Sculpher and Panelist Beth Woods

Spotlight session 16.00 - 17.00 


Health equity in HEOR: The state of play

Session speaker Richard Cookson 

ISPOR Forums 16:00 - 17:00


Thursday 2 December

Cost effectiveness analysis of diagnostic and screening strategies: When and how to compare a googolplex of strategies?

Discussant Rita Faria

Issue  Panels and workshops - Live workshop 12.30-13.30


Friday 3 December 

See the future: How important will structured expert elicitation become for HTA in the next 5 years?

Discussant Laura Bojke

Issue  Panels and workshops - Live workshop 11.30-12.00